Memorial Bahçelievler is a large Memorial Health Group hospital in Istanbul with 320 beds, 19 operating rooms, LEED Platinum certification, advanced oncology technology and services for patients from 92 countries.
Memorial Bahçelievler is a major Memorial Health Group hospital in Istanbul, designed as a comprehensive medical campus with advanced technology, experienced clinical teams and architecture focused on patient comfort.
As the 11th hospital project of Memorial Health Group, Memorial Bahçelievler reflects the group’s experience in diagnosis, treatment, intensive care and international patient services. The hospital presents Memorial’s model in the center of Istanbul with a setting planned for patients, relatives and clinical teams.
The hospital operates on a total area of 72,000 square meters, including 8,000 square meters of green space. It has 320 beds, 19 operating rooms including one hybrid operating room, 49 intensive care beds, 135 outpatient clinics and 31 observation rooms. This capacity supports outpatient assessment, surgery, postoperative monitoring and intensive care within one coordinated Istanbul hospital.
Memorial Bahçelievler provides specialized treatment and surgery across expert branches, supported by advanced imaging units, complex laboratories, intensive care units, hybrid operating rooms, robotic applications and dedicated centers for multidisciplinary care. Clinical programs include diagnosis, treatment planning and follow-up across surgical and medical specialties, with teams structured for local patients and international patients who need coordinated appointments.
The hospital’s infrastructure includes Elekta Versa HD SIGNATURE radiation therapy, robotic surgery, MRI, CT, PET-CT, gamma camera, X-ray, mammography, fluoroscopy, ultrasound, echocardiography and angiography. 3 Tesla MRI supports high-resolution imaging, dual-energy CT scans body regions within seconds, PET-CT supports cancer diagnosis and staging, and da Vinci robotic surgery is used especially in urology, kidney transplantation, gynecology and general surgery. Together, these systems allow Memorial Bahçelievler to combine imaging, oncological treatment, minimally invasive surgery and intensive care in the same Istanbul campus.
Memorial Bahçelievler received LEED Platinum certification from USGBC, the highest rating for energy and environmentally responsible design. It was awarded as the first fully equipped hospital in Turkey and worldwide to receive this certification.
The hospital was built with criteria such as energy efficiency, waste management, sustainable site planning and indoor air quality. Green areas, non-allergenic plants, daylight use and art-focused design are used to create a calmer environment for patients, relatives and staff without replacing medical treatment. These design choices are presented as part of the hospital experience: easier orientation inside the building, more comfortable waiting areas and a less stressful care setting.
Accepting patients from 92 countries worldwide, Memorial Bahçelievler serves international patients with its International Health Tourism Authorization Certificate and Memorial departments recognized as reference centers in international fields. For medical tourism in Istanbul, the hospital combines the Memorial Health Group brand, broad clinical capacity, environmental certification and a location suited to patients seeking specialist consultation, surgery or second opinions in Turkey.
Place of Birth: Elazığ
Date of Birth: 1973
Foreign Language: English
2023 - Present, Istanbul/Turkey MEMORIAL BAHÇELİEVLER HOSPITAL Medical Oncology Specialist 2017 - 2023, Malatya/Turkey INÖNÜ UNIVERSITY FACULTY OF MEDICINE DEPARTMENT OF INTERNAL MEDICINE Medical Oncology Specialist 2009 - 2011, Istanbul/Turkey MINISTRY OF HEALTH ŞİŞLİ TRAINING AND RESEARCH HOSPITAL MEDICAL ONCOLOGY CLINIC Medical Oncology Clinic 2007 - 2009, Ankara/Turkey HACETTEPE UNIVERSITY FACULTY OF MEDICINE DEPARTMENT OF INTERNAL MEDICINE ONCOLOGY DIVISION Medical Oncology Specialist 2004 - 2007, Ankara/Turkey HACETTEPE UNIVERSITY FACULTY OF MEDICINE ONCOLOGY INSTITUTE ONCOLOGY DEPARTMENT Medical Oncology Specialist 1998 - 2004, Malatya/Turkey INÖNÜ UNIVERSITY FACULTY OF MEDICINE DEPARTMENT OF INTERNAL MEDICINE Medical Oncology Specialist 1991 - 1998, Ankara / Turkey/Turkey HACETTEPE UNIVERSITY FACULTY OF MEDICINE
2017 - Present, Malatya / Turkey INÖNÜ UNIVERSITY FACULTY OF MEDICINE / PROFESSOR 2004 - 2009, Malatya / Turkey INÖNÜ UNIVERSITY FACULTY OF MEDICINE Internal Medicine Specialization Training 1998 - 2004, Ankara / Turkey HACETTEPE UNIVERSITY FACULTY OF MEDICINE Medical Education
International phase III study for patients with gastrointestinal stromal tumors who are not suitable for participation in other SU 011248 protocols and who are resistant to imatinib mesylate or intolerant to imatinib mesylate EMR 62 202-013 Open randomized controlled multicenter phase III study comparing 5-fufa with 5-fufa-irinotecan-cetuxiab treatment in first-line treatment of EGFR-expressing metastatic colorectal cancer Open randomized multicenter international phase III study comparing trastuzumab in combination with a fluoropyrimidine and cisplatin versus chemotherapy alone as first-line treatment in patients with HER2-positive advanced gastric cancer Randomized open multicenter phase II study evaluating the efficacy and safety of folfox6 + cetuximab versus folfırı + cetuximab as first-line treatment in patients with metastatic colorectal cancer Double-blind placebo-controlled randomized multicenter phase 3 study evaluating the efficacy and safety of pertuzumab given in combination with trastuzumab and chemotherapy in patients with HER2-positive metastatic gastroesophageal junction and gastric cancer (JACOB) Phase 2 multicenter, single-arm MPDL3280A study in patients with PD-L1 positive locally advanced or metastatic non-small cell lung cancer Randomized, multicenter, open-label phase 3 study evaluating the efficacy and safety of trastuzumab emtansine versus trastuzumab as adjuvant treatment for HER2-positive primary breast cancer patients with pathological residual tumor in the breast or axillary lymph nodes after preoperative treatment (KATHERINA) Randomized, two-arm, open-label, multicenter phase 2 study evaluating the efficacy and safety of pertuzumab given in combination with trastuzumab and an aromatase inhibitor in HER2-positive and hormone receptor-positive advanced (metastatic or locally advanced) first-line breast cancer patients (PERTOIN) Placebo-controlled, randomized, double-blind, phase 3 study comparing LY2835219, a CDK4/6 inhibitor, or placebo with nonsteroidal aromatase inhibitors (anastrozole or letrozole) in women with hormone receptor-positive, HER2-negative, postmenopausal, locally recurrent or metastatic breast cancer who have not previously received systemic therapy Expanded access clinical program with Tarceva in patients with advanced stage IIIb/IV non-small cell lung cancer The safety and efficacy of LONQUEX (lipegfilgrastim) compared with pegfilgrastim (Neulasta, Amgen) and placebo in patients with non-small cell lung cancer receiving first-line chemotherapy (TEVA) Randomized, multicenter, phase 3, open-label study of alektinib versus crizotinib in previously untreated, ALK-positive, advanced non-small cell lung cancer (ALEX) Phase III, randomized, double-blind, placebo-controlled, multicenter, international study of MEDI4736 as sequential therapy in patients with locally advanced, unresectable, non-small cell lung cancer (stage III) who do not progress after definitive, platinum-based, concurrent chemoradiotherapy (PACIFIC) Placebo-controlled, randomized, double-blind, phase 3 comparing ramucirumab with docetaxel versus placebo with docetaxel in patients with locally advanced or surgically unresectable or metastatic urothelial carcinoma who experienced progression during or after platinum-based treatment Open-label, randomized, multicenter, phase 2 comparing veliparib plus carboplatin and paclitaxel versus the investigator’s choice of standard chemotherapy in volunteers who currently smoke or have smoked previously and are receiving first cytotoxic chemotherapy for metastatic or advanced non-squamous non-small cell lung cancer (NSCLC) Phase 3 randomized clinical study of pembrolizumab (MK-3475) versus paclitaxel, docetaxel or vinflunine in recurrent or metastatic urothelial cancer - MK3475-045 Phase 3 clinical study of pembrolizumab (MK-3475) in the first-line treatment of recurrent/metastatic squamous cell carcinoma of the head and neck - MK3475-048 Phase II clinical study evaluating the efficacy and safety of pembrolizumab (MK-3475) in volunteers with high-risk, non-muscle-invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG) treatment. (Protocol No: MK-3475-057) Phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of combined GS-5745 and mFOLFOX6 treatment as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma (GILEAD) In volunteers with advanced hepatocellular carcinoma who had previously received systemic treatment
Intestinal Infection Colic in Infants Acute Gastroenteritis (Diarrhea) Lower Respiratory Tract Infections Fever and Rash Diseases Food Allergy (Food Allergy) Throat Infection Bronchiolitis Pneumonia Treatment Methods Vaccination Follow-Up Monitoring Child Development in Children Healthy Child Follow-Up Bronchiolitis Pneumonia Breast Milk and Maternal Nutrition Asthma Diagnosis and Treatment Diagnosis and Treatment of Pediatric Infectious Diseases Vaccination and Counseling in Healthy and Risk Group Children Newborn Follow-Up Specialized Expertise
Date of Birth: Kayseri / Turkey /1985
Foreign Language: English E-MAIL ADDRESS [email protected]
2023 - Present, Istanbul/Turkey Memorial Bahçelievler Hospital Pediatric Specialist 2023 - 2023, Istanbul/Turkey Medicana International (Beylikdüzü) Hospital Pediatric Specialist 2022 - 2022, Istanbul/Turkey Avicenna Esenler Hospital Pediatric Specialist 2022 - 2023, Istanbul/Turkey Istinye University Bahçeşehir Liv Pediatric Specialist 2021 - 2022, Istanbul/Turkey Başakşehir Medical Center Pediatric Specialist 2019 - 2021, Istanbul/Turkey Memorial Bahçelievler Hospital Pediatric Specialist 2018 - 2019, Istanbul/Istanbul/Turkey Istinye University Liv Hospital Pediatric Specialist - Faculty Member 2018 - 2019, Istanbul/Turkey Istinye University Liv Hospital Pediatric Specialist Faculty Member 2017 - 2018, Hatay/Hatay/Turkey Private Reyhanlı Sevgi Hospital Pediatric Specialist 2017 - 2018, Hatay/Turkey Private Reyhanlı Sevgi Hospital Pediatric Specialist 2015 - 2017, Hatay/Hatay/Turkey Antakya Obstetrics and Gynecology and Children's Diseases Hospital Pediatric Specialist – Mandatory Service 2015 - 2017, Hatay/Turkey Antakya Obstetrics and Gynecology and Children's Diseases Hospital Pediatric Specialist – Mandatory Service
2010 - 2015, Istanbul/Turkey Şişli Etfal Training and Research Hospital Pediatric Specialty Training 2010 - 2014, Istanbul/Turkey Şişli Etfal Training and Research Hospital Pediatric Specialty Training 2003 - 2010, Istanbul/Turkey Istanbul University Cerrahpaşa Faculty of Medicine Medical Doctor Training 2003 - 2010, Istanbul/Turkey Istanbul University Cerrahpaşa Faculty of Medicine Medical Doctor Training
7 papers presented at national congresses
Turkish Medical Association
Newborn Update Course for Pediatrics Specialist, 2015 3. Congress of Child Friends, 2015 Ege University 2. Simulated Practical Newborn Invasive Interventions Course, 2014 Neonatal Resuscitation Program Course, 2013 1. Congress of Child Friends and Newborn, 2013 57. Turkey National Pediatrics Congress, 2013 Advanced Life Support in Children Course, 2013
Place of Birth: Kırklareli
Date of Birth: 1975
Foreign Language: English
2024 - Present, İstanbul/Turkey MEMORIAL BAHÇELİEVLER HOSPITAL Specialist in Pediatrics 2023 - 2024, İstanbul/Turkey MEMORIAL HİZMET HOSPITAL Specialist in Pediatrics 2022 - 2023, İstanbul/Turkey ÖZEL LİV VADİ İSTANBUL HOSPITAL Specialist in Pediatrics 2012 - 2022, İstanbul/Turkey MEMORIAL HİZMET HOSPITAL Specialist in Pediatrics 2008 - 2012, İstanbul/Turkey ÖZEL KOLAN HOSPITAL Specialist in Pediatrics 2003 - 2008, İstanbul/Turkey ÖZEL GAZİOSMANPAŞA HOSPITAL Specialist in Pediatrics 2002 - 2003, İstanbul/Turkey JFK HOSPITAL Specialist in Pediatrics
1998 - 2002, İstanbul İSTANBUL UNIVERSITY Department of Pediatrics Specialization Training 1991 - 1997, İstanbul İSTANBUL UNIVERSITY Medical Doctor Training
Pediatric Endocrinology Congress and Pediatric Endocrinology Emergencies Training Course Pediatric Congress Research Statistics Training Course Neonatal Resuscitation Course National Pediatrics Congress Pediatric Emergency Medicine Course Turkish Pediatrics Congress Pediatric Infectious Diseases Congress Europediatrics
İstanbul Chamber of Medicine Turkish Pediatrics Society
Articles in National and International Journals Various Oral Presentations at National and International Congresses Spec. Dr. Hüseyin Cem ÖCAL Health Articles Things to Pay Attention to for a Healthy School Season Spec. Dr. Hüseyin Cem ÖCAL Read All Articles
Premature Ejaculation Sexual Impotence Urinary Incontinence and Organ Prolapse in Women Kidney and Urinary Tract Stone Diseases Urethral Stricture (External Urinary Tract Stricture) Benign Prostate Enlargement Bladder Cancer Prostate Cancer Kidney Cancer Chronic Cystitis, Chronic Prostatitis and Painful Bladder Syndrome Treatment Methods Laparoscopic Radical / Partial Nephrectomy Percutaneous Nephrolithotomy (PCNL), Ureterorenoscopy (URS) Urethroplasty and Endoscopic Treatment of Urethral Strictures Penile Prosthesis Implantation HOLEP-REZUM Urinary Incontinence (TOT, TVT) and Organ Prolapse Surgeries Microscopic Varicocelectomy and Microscopic TESE Surgery REZUM Method (Steam Therapy) Specialized Expertise OTHER HOSPITALS AND UNITS HE WORKED IN Bahçelievler Hospital Robotic Surgery Center Bahçelievler Hospital Andrology
Place of Birth: Kilis
Date of Birth: 1990
Foreign Language: English
2024 - Present, / MEMORIAL BAHÇELİEVLER HOSPITAL Urology Specialist 2020 - 2024, Istanbul/Turkey BAŞAKŞEHİR ÇAM VE SAKURA CITY HOSPITAL Urology Specialist 2014 - 2015, /Turkey MUSABEYLİ STATE HOSPITAL General Practitioner
2025 - Present, Istanbul/Turkey ISTANBUL AREL UNIVERSITY Department of Urology Lecturer 2015 - 2020, Istanbul/Turkey BAKIRKÖY DR. SADİ KONUK TRAINING AND RESEARCH HOSPITAL Specialization Training 2008 - 2014, Istanbul/Turkey ISTANBUL UNIVERSITY, CERRAHPAŞA FACULTY OF MEDICINE Medical Doctor Training
28 publications in international, 14 in national peer-reviewed journals Authorship of 6 book chapters 60 papers and invited speaker at national congresses 6 papers at international congresses
European Association of Urology Turkish Urology Association Eurasian Urooncology Association Endourology Association Turkish Medical Association
European Urology Board Certificate (FEBU) Robotic Surgery Certificate (Multiport-Single Port) Robotic Kidney Transplantation and Surgeries Course Genitourinary System Prostheses Surgery Course ICS Urodynamics Certificate Participant and speaker at over 50 congresses, symposiums and meetings Assoc. Prof. Dr. Yunus ÇOLAKOĞLU Health Articles Pay Attention to the Varicocele Problem Seen in 15 Out of 100 Men! Assoc. Prof. Dr. Yunus ÇOLAKOĞLU Read All Articles
Acıbadem Altunizade Hospital in Istanbul is a JCI-accredited Acıbadem facility with 350 beds, advanced oncology, robotic surgery, intensive care and 16-language Health Point support for international patients.
Acıbadem Maslak Hospital in Istanbul is the largest Acıbadem hospital, with 106,000 m², 288 beds, advanced oncology, robotic surgery, IVF, pediatric care and international-patient appeal.
Liv Hospital Bahçeşehir is a tertiary healthcare hospital in Istanbul with organ transplant, stroke, oncology, IVF, interventional radiology, pediatric intensive care, and health tourism accreditation.
